Saumya Subramanian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Saumya Subramanian has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Divya Kanchibhotla
Sri Sri Institute For Advanced Research
7 shared publications - Hari Venkatesh
Sriveda Sattva Pvt. Ltd
4 shared publications - Ravi Reddy
Sriveda Sattva Pvt. Ltd
4 shared publications - Vinod Mony
Sri Sri Institute For Advanced Research
2 shared publications A. T. Lakshmi
Sri Sri Institute For Advanced Research
1 shared publicationAnuradha Rajaram
Research, Sri Sri Institute for Advanced Research, Bangalore, Karnataka, India
1 shared publication
Latest Publications
- 3 June 2026
- Published by Springer Nature
- p. 263-278
Bactericidal Potential of Traditional Herbal Fire Ceremony, Yagnas: A Complete Microbiological Evaluation
- 3 June 2026
- Published by Springer Nature
- p. 263-278
Bactericidal Potential of Traditional Herbal Fire Ceremony, Yagnas: A Complete Microbiological Evaluation
- 21 April 2026
- Published by SAGE Publications in Clinical Child Psychology and Psychiatry
- Vol. 31 (3) , 960-979
Can Yoga and Meditation Practice Motivate Teenagers to Adopt a Healthier Lifestyle: An Epidemiological Study
Background: The rapid technological growth and the ease of access to Internet to the current generation population (Generation Z, alpha) right from their early days of life, has its both advantages and disadvantages. The present epidemiological study evaluates the impact of yoga and meditation practices on the teenagers’ mental health and lifestyle choices. Methods: The total sample size is 425, of age group 13–19, 237 were practicing either yoga, meditation or both, while 188 practiced neither meditation nor yoga. Several different parameters were assessed via the PROMIS pediatric forms. Several lifestyle habits were also assessed using subjective questions. Results: Our study has demonstrated that teens who practiced yoga and meditation had a significantly positive effect on the parameters such as positive affect ( p value <.001), global health ( p value = .03) and cognitive health ( p value = .02) compared to their peers who did not practice any yoga or meditation. It was also shown a negative effect on parameters such as psychological stress experiences ( p value = .06), sleep related problems ( p value = .41). Conclusions: Along with the mental and cognitive health, the decisions and choices made by the teenagers who practice yoga and meditation are shown to be better than their peers in this Indian epidemiological study.
- 21 April 2026
- Published by SAGE Publications in Clinical Child Psychology and Psychiatry
- Vol. 31 (3) , 960-979
Can Yoga and Meditation Practice Motivate Teenagers to Adopt a Healthier Lifestyle: An Epidemiological Study
Background: The rapid technological growth and the ease of access to Internet to the current generation population (Generation Z, alpha) right from their early days of life, has its both advantages and disadvantages. The present epidemiological study evaluates the impact of yoga and meditation practices on the teenagers’ mental health and lifestyle choices. Methods: The total sample size is 425, of age group 13–19, 237 were practicing either yoga, meditation or both, while 188 practiced neither meditation nor yoga. Several different parameters were assessed via the PROMIS pediatric forms. Several lifestyle habits were also assessed using subjective questions. Results: Our study has demonstrated that teens who practiced yoga and meditation had a significantly positive effect on the parameters such as positive affect ( p value <.001), global health ( p value = .03) and cognitive health ( p value = .02) compared to their peers who did not practice any yoga or meditation. It was also shown a negative effect on parameters such as psychological stress experiences ( p value = .06), sleep related problems ( p value = .41). Conclusions: Along with the mental and cognitive health, the decisions and choices made by the teenagers who practice yoga and meditation are shown to be better than their peers in this Indian epidemiological study.
- Open Access
Preclinical and Clinical Study of Efficacy of NAOQ19 against SARS-COV2: A Comprehensive Evaluation
Background: More than 6.2 million people have died already from COVID-19. Drug resistance and relapse cases from first generation therapeutics calls for development of new drugs in alternative medicine. Complementary and Alternative Medicines (CAM) that include herbal remedies and phytochemicals are usually not fully integrated into mainstream healthcare systems. The study proposes a CAM remedy, a new polyherbal formulation ‘NAOQ19’ against the SARS-CoV-2. Methods: The present study consists of invitro and invivo evaluation of NAOQ19 against SARS-CoV-2 infection. First, invitro testing of NAOQ19 anti-viral activity was carried out on three relevant cell lines: Vero E6, A549ACE2 and Huh 7.5.1 ACE2TMPRSS2. Next, animal model testing of NAOQ19 was performed in Syrian golden hamsters along with positive control Remdesivir and infection control for 3 days to determine the efficacy and safety of the formulation. Finally, a double blind randomized clinical trial with mild to moderate COVID-19 infected patients were evaluated to test the efficacy of NAOQ19 in human settings. Results: This study demonstrated a strong anti-viral (low EC50) activity in cell culture with live virus and exhibits reduced plaque forming units (high antiviral activity) in the Syrian golden hamster model. Moreover, in the clinical trials, NAOQ19 shows high efficacy demonstrating early recovery and reduced levels of inflammatory biomarkers among COVID-19 infected patients. Conclusion: This novel polyherbal formulation NAOQ19, demonstrates strong anti-viral activity in preclinical and clinical study; thereby proving its candidacy as a low-cost alternative medicine with minimal adverse effects.
Open AccessPreclinical and Clinical Study of Efficacy of NAOQ19 against SARS-COV2: A Comprehensive Evaluation
Background: More than 6.2 million people have died already from COVID-19. Drug resistance and relapse cases from first generation therapeutics calls for development of new drugs in alternative medicine. Complementary and Alternative Medicines (CAM) that include herbal remedies and phytochemicals are usually not fully integrated into mainstream healthcare systems. The study proposes a CAM remedy, a new polyherbal formulation ‘NAOQ19’ against the SARS-CoV-2. Methods: The present study consists of invitro and invivo evaluation of NAOQ19 against SARS-CoV-2 infection. First, invitro testing of NAOQ19 anti-viral activity was carried out on three relevant cell lines: Vero E6, A549ACE2 and Huh 7.5.1 ACE2TMPRSS2. Next, animal model testing of NAOQ19 was performed in Syrian golden hamsters along with positive control Remdesivir and infection control for 3 days to determine the efficacy and safety of the formulation. Finally, a double blind randomized clinical trial with mild to moderate COVID-19 infected patients were evaluated to test the efficacy of NAOQ19 in human settings. Results: This study demonstrated a strong anti-viral (low EC50) activity in cell culture with live virus and exhibits reduced plaque forming units (high antiviral activity) in the Syrian golden hamster model. Moreover, in the clinical trials, NAOQ19 shows high efficacy demonstrating early recovery and reduced levels of inflammatory biomarkers among COVID-19 infected patients. Conclusion: This novel polyherbal formulation NAOQ19, demonstrates strong anti-viral activity in preclinical and clinical study; thereby proving its candidacy as a low-cost alternative medicine with minimal adverse effects.
- 20 January 2025
- Published by SAGE Publications in Clinical Child Psychology and Psychiatry
- Vol. 30 (2) , 452-464
Effect of yogic breathing practice on all-round well-being of teenagers
Adolescence is a critical life period that marks the transition into adulthood. This novel study aims to evaluate the benefits of 4- day intervention, Sudarshan Kriya Yoga (SKY), a breathing technique, on the emotional, mental, and cognitive health of teenagers. Open label trial tests were administered at pre-intervention, immediately after SKY, and after 40 days of SKY practice. Cognitive abilities of 275 adolescents were tested using the Six letter cancellation test. Mental well-being was assessed using the World Health Organization-five Index (WHO-5), and Emotional well-being using the Strength and Difficulty Questionnaire (SDQ) questionnaire. The Results were analyzed using a paired-sample t test. The results showed an improvement in cognitive abilities for 71% of the study population as measured by the six-letter cancellation test, better mental health scores for 86%, and better SDQ scores for 95% of the population after SKY practice.
- 20 January 2025
- Published by SAGE Publications in Clinical Child Psychology and Psychiatry
- Vol. 30 (2) , 452-464
Effect of yogic breathing practice on all-round well-being of teenagers
Adolescence is a critical life period that marks the transition into adulthood. This novel study aims to evaluate the benefits of 4- day intervention, Sudarshan Kriya Yoga (SKY), a breathing technique, on the emotional, mental, and cognitive health of teenagers. Open label trial tests were administered at pre-intervention, immediately after SKY, and after 40 days of SKY practice. Cognitive abilities of 275 adolescents were tested using the Six letter cancellation test. Mental well-being was assessed using the World Health Organization-five Index (WHO-5), and Emotional well-being using the Strength and Difficulty Questionnaire (SDQ) questionnaire. The Results were analyzed using a paired-sample t test. The results showed an improvement in cognitive abilities for 71% of the study population as measured by the six-letter cancellation test, better mental health scores for 86%, and better SDQ scores for 95% of the population after SKY practice.
- Open Access
- 23 June 2022
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 13 (3) , 100581
An In-vitro evaluation of a polyherbal formulation, against SARS-Cov-2
- 23 June 2022
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 13 (3) , 100581
Open AccessAn In-vitro evaluation of a polyherbal formulation, against SARS-Cov-2
- Open Access
- 10 November 2021
- Published by Springer Nature in Research Square
Rate of Recovery and Symptomatic Efficacy of a Polyherbal AYUSH Formulation in the Treatment of SARS CoV-2 disease: A Single-arm trial
Background The COVID-19 pandemic, caused by the human coronavirus SARS- CoV-2, has led to millions of deaths across the globe. Not only is the SARS-CoV-2 virus highly infectious, it also mutates very easily. This creates additional challenges for development of robust therapeutic solutions. Along with modern system of healthcare, there is a definite need for exploring natural plant based antiviral compounds directed against the SARS CoV-2 virus. Objective The present observational study investigates the efficacy of an Ayurvedic polyherbal formulation of 19 ingredients, NOQ19, in the management of COVID-19. Methodology: A single arm, single centric, open label study design was adopted for this feasibility study. 161 RT-PCR positive COVID-19 patients were enrolled. The enrolled participants were provided the Ayurvedic intervention, 2 tablets of NOQ19, thrice daily along with the standard of care treatment. Follow up COVID-19 RT- PCR tests were conducted on Day 5, Day 10 and Day 14, or until the patient turned negative. The time required for testing negative on the RT-PCR test or becoming asymptomatic was noted. Results A subjective analysis demonstrated that 74% of patients turned RT-PCR negative within 5 days of taking NOQ19. Additionally, 98% of the subjects turned RT-PCR Negative on Day 10 after taking NOQ19 in addition to the standard of care treatment of Vitamin C, Zinc and antipyretic (as necessary). None of the participants reported any adverse or side effects to the medication. Conclusion NOQ19 Ayurvedic polyherbal formulation can be an effective and safe option for the symptomatic management of COVID-19.
- 10 November 2021
- Published by Springer Nature in Research Square
Open AccessRate of Recovery and Symptomatic Efficacy of a Polyherbal AYUSH Formulation in the Treatment of SARS CoV-2 disease: A Single-arm trial
Background The COVID-19 pandemic, caused by the human coronavirus SARS- CoV-2, has led to millions of deaths across the globe. Not only is the SARS-CoV-2 virus highly infectious, it also mutates very easily. This creates additional challenges for development of robust therapeutic solutions. Along with modern system of healthcare, there is a definite need for exploring natural plant based antiviral compounds directed against the SARS CoV-2 virus. Objective The present observational study investigates the efficacy of an Ayurvedic polyherbal formulation of 19 ingredients, NOQ19, in the management of COVID-19. Methodology: A single arm, single centric, open label study design was adopted for this feasibility study. 161 RT-PCR positive COVID-19 patients were enrolled. The enrolled participants were provided the Ayurvedic intervention, 2 tablets of NOQ19, thrice daily along with the standard of care treatment. Follow up COVID-19 RT- PCR tests were conducted on Day 5, Day 10 and Day 14, or until the patient turned negative. The time required for testing negative on the RT-PCR test or becoming asymptomatic was noted. Results A subjective analysis demonstrated that 74% of patients turned RT-PCR negative within 5 days of taking NOQ19. Additionally, 98% of the subjects turned RT-PCR Negative on Day 10 after taking NOQ19 in addition to the standard of care treatment of Vitamin C, Zinc and antipyretic (as necessary). None of the participants reported any adverse or side effects to the medication. Conclusion NOQ19 Ayurvedic polyherbal formulation can be an effective and safe option for the symptomatic management of COVID-19.
- Open Access
- 28 September 2021
- Published by Springer Nature in Research Square
To study the in-vivo efficacy and safety of AYUSH polyherbal formulation among COVID-19 infected Syrian gold hamsters
The COVID-19 pandemic has infected millions of people around the world and the resulting disease burden has challenged the already stressed healthcare systems globally. Amidst the increasing morbidity rate of SARS-CoV-2, the scientific community is vigorously researching possible remedies targeted against the virus. Natural herbs have a great potency to cure infectious diseases and are vastly unexplored. The present study aims to investigate Ayurvedic herbs in a unique polyherbal formulation, NOQ19, against the SARS-CoV-2 virus in an animal model. A total of 19 female Syrian hamsters were infected with the virus cell culture through intranasal route. 4 out of 19 animals were mock controls, 5 were infection controls, 4 were treated with remdesivir and acted as positive controls and remaining 6 were treated with NOQ19. The hamsters were observed to note body weight reduction and adverse events followed by sacrifice on day 4 after inoculation with the virus. The lung pathology and viral load was studied in each hamster. Results showed a significant reduction of 78.2% in the viral load for the NOQ19 arm, as compared to the infection control. Gross examination of the lung histology of the NOQ19 arm suggested an improvement in edema and congestion compared to the infection control. Also, no adverse events were noticed in NOQ19 hamster group. Therefore, the authors propose NOQ19 formulation as a potential option to be tested further for its efficacy and efficiency against COVID-19.
- 28 September 2021
- Published by Springer Nature in Research Square
Open AccessTo study the in-vivo efficacy and safety of AYUSH polyherbal formulation among COVID-19 infected Syrian gold hamsters
The COVID-19 pandemic has infected millions of people around the world and the resulting disease burden has challenged the already stressed healthcare systems globally. Amidst the increasing morbidity rate of SARS-CoV-2, the scientific community is vigorously researching possible remedies targeted against the virus. Natural herbs have a great potency to cure infectious diseases and are vastly unexplored. The present study aims to investigate Ayurvedic herbs in a unique polyherbal formulation, NOQ19, against the SARS-CoV-2 virus in an animal model. A total of 19 female Syrian hamsters were infected with the virus cell culture through intranasal route. 4 out of 19 animals were mock controls, 5 were infection controls, 4 were treated with remdesivir and acted as positive controls and remaining 6 were treated with NOQ19. The hamsters were observed to note body weight reduction and adverse events followed by sacrifice on day 4 after inoculation with the virus. The lung pathology and viral load was studied in each hamster. Results showed a significant reduction of 78.2% in the viral load for the NOQ19 arm, as compared to the infection control. Gross examination of the lung histology of the NOQ19 arm suggested an improvement in edema and congestion compared to the infection control. Also, no adverse events were noticed in NOQ19 hamster group. Therefore, the authors propose NOQ19 formulation as a potential option to be tested further for its efficacy and efficiency against COVID-19.
- Open Access
- 28 September 2021
- Published by Springer Nature in Research Square
An In-vitro evaluation of a polyherbal formulation, against SARS-CoV-2
Background: COVID-19, caused by SARS-CoV-2 is one of the major health crisis that has affected the world in the past century. With the emergence of new strains of viruses and antimicrobial resistance, the world is looking for an alternate therapeutic option to fight infectious disease.Objective: The present study evaluated the efficacy of a novel polyherbal formulation, named NOQ19, against SARS-CoV-2 in an in vitro setting. NOQ 19 is an unique blend of 13 Ayurvedic herbs.Methodology: Vero E6 (CL1008), the African green monkey kidney epithelial cell, were infected with SARS-CoV-2 virus (isolate USA-WA1/2020) in a 96 well-plate. NOQ19 test material was diluted in different concentration as follows 0.05mg/ml, 0.1mg/ml, 0.2mg/ml, 0.3mg/ml, 0.4mg/ml, 0.5mg/ml, 0.6mg/ml, 0.7mg/ml, 0.8mg/ml and 0.9mg/ml. These different concentrations of NOQ19 were added to infected cells respectively and incubated for 3 days in 5% CO2 incubator. Remdesivir was used as a positive control.The cells were finally fixed with formaldehyde, stained with crystal violet and plaques were visualized. The number of plaques were counted to determine the PFU(plaque forming units)/mL.Results: Results demonstrated 100% antiviral efficacy of NOQ19 at 0.9mg/ml concentration with complete elimination of the virus. The IC50 of the drug was found to be 0.2mg/ml. The results of the present study demonstrated viral load reduction in SARS- CoV-2 infected Vero E6 cell lines.Conclusion: The result along with clinical trials could propose NOQ19 as a potential therapeutic option in the fighting the COVID-19 challenge.
- 28 September 2021
- Published by Springer Nature in Research Square
Open AccessAn In-vitro evaluation of a polyherbal formulation, against SARS-CoV-2
Background: COVID-19, caused by SARS-CoV-2 is one of the major health crisis that has affected the world in the past century. With the emergence of new strains of viruses and antimicrobial resistance, the world is looking for an alternate therapeutic option to fight infectious disease.Objective: The present study evaluated the efficacy of a novel polyherbal formulation, named NOQ19, against SARS-CoV-2 in an in vitro setting. NOQ 19 is an unique blend of 13 Ayurvedic herbs.Methodology: Vero E6 (CL1008), the African green monkey kidney epithelial cell, were infected with SARS-CoV-2 virus (isolate USA-WA1/2020) in a 96 well-plate. NOQ19 test material was diluted in different concentration as follows 0.05mg/ml, 0.1mg/ml, 0.2mg/ml, 0.3mg/ml, 0.4mg/ml, 0.5mg/ml, 0.6mg/ml, 0.7mg/ml, 0.8mg/ml and 0.9mg/ml. These different concentrations of NOQ19 were added to infected cells respectively and incubated for 3 days in 5% CO2 incubator. Remdesivir was used as a positive control.The cells were finally fixed with formaldehyde, stained with crystal violet and plaques were visualized. The number of plaques were counted to determine the PFU(plaque forming units)/mL.Results: Results demonstrated 100% antiviral efficacy of NOQ19 at 0.9mg/ml concentration with complete elimination of the virus. The IC50 of the drug was found to be 0.2mg/ml. The results of the present study demonstrated viral load reduction in SARS- CoV-2 infected Vero E6 cell lines.Conclusion: The result along with clinical trials could propose NOQ19 as a potential therapeutic option in the fighting the COVID-19 challenge.